Genetic Clues for Skin Cancer Therapies Oswego NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Peachey John C MD
(585) 383-4420
220 E Linden Ave
East Rochester, NY
Ellen Maruca Make-Up Studio
(516) 621-6884
1524 Old Northern Blvd
Roslyn, NY
Valente Domenico MD Dermatologic Surgeon
(212) 593-1818
260 E 66th St
New York, NY
Yager Jeffery MD Plastic Surgeon
(212) 593-1818
260 E 66th St
New York, NY
Center For Dermatology & Skin Surgery
(516) 371-1600
135 Rockaway Tpke
Lawrence, NY
Farah Dermatology & Cosmetics
(315) 593-2730
522 S 4th St
Fulton, NY
Mehta Leena MD
(585) 637-9196
80 West Ave
Brockport, NY
Kaufman Tara MD
(631) 444-4200

Stony Brook, NY
Toback Arnold MD
(212) 737-1440
2 E 69th St
New York, NY
Blank Ellen
(718) 987-3300
1122 Richmond Ave
Staten Island, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Getting a Botox Cosmetic Injection Oswego NY
Aging is something that everyone is going to have to deal with. However, because of genetic factors, some people tend to age far better than others. Take, for example, various Asian cultures. Because of their climate and diet, they have become genetically predisposed to having very few wrinkles.
- Breast Cancer Treatment Oswego NY
- Delayed Prostate Cancer Therapy Oswego NY
- Filling in Wrinkles with Dermal Fillers Oswego NY
- Risk Factors for Squamous Cell Cancer of the Skin Oswego NY
- Healing Facial Spider Veins Oswego NY
- Risks for Childhood Cancer Survivors Oswego NY
- Follow Up After Skin Cancer Oswego NY
- Gene Mutation in Dogs Oswego NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Oswego NY